Apex Biotechnology Corp 1733
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 33.90
- Day Range
- TWD 33.65–33.90
- 52-Week Range
- TWD 25.60–44.45
- Bid/Ask
- TWD 33.70 / TWD 33.85
- Market Cap
- TWD 3.37 Bil
- Volume/Avg
- 183,000 / 1.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 24.66
- Price/Sales
- 2.02
- Dividend Yield (Trailing)
- 4.17%
- Dividend Yield (Forward)
- 4.17%
- Total Yield
- 4.15%
Company Profile
Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 641
- Website
- https://www.apexbio.com
Comparables
Valuation
|
Metric
|
1733
|
4142
|
4736
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.66 | 1,643.78 | 13.77 |
Price/Book Value | 1.87 | 2.08 | 1.66 |
Price/Sales | 2.02 | 6.38 | 3.09 |
Price/Cash Flow | 14.98 | — | 31.97 |
Price/Earnings
1733
4142
4736
Financial Strength
|
Metric
|
1733
|
4142
|
4736
|
|---|---|---|---|
Quick Ratio | 1.93 | 2.12 | 2.53 |
Current Ratio | 3.93 | 2.63 | 3.09 |
Interest Coverage | 32.72 | −22.58 | 102.66 |
Quick Ratio
1733
4142
4736
Profitability
|
Metric
|
1733
|
4142
|
4736
|
|---|---|---|---|
Return on Assets (Normalized) | 5.77% | −3.83% | 8.25% |
Return on Equity (Normalized) | 7.75% | −6.10% | 11.89% |
Return on Invested Capital (Normalized) | 7.10% | −3.83% | 9.70% |
Return on Assets
1733
4142
4736
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Rhccfzrc | Dyvx | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fcljcljcv | Ktrdn | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gqffqdnmz | Rkfbvwv | $97.8 Bil | |
MRNA
| Moderna Inc | Lsynlwfk | Xsb | $38.8 Bil | |
ARGX
| argenx SE ADR | Vhdbddktc | Kkl | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Zctbrkpmv | Cmzgy | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Xrhkmnnl | Gxmcwdq | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Nnwhywxp | Rhlqpv | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Npbfhpgry | Zvnzkx | $12.5 Bil | |
INCY
| Incyte Corp | Hgddpqyb | Qkrpy | $11.5 Bil |